SCOTIA CAPITAL INC. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 871 filers reported holding NOVARTIS A G in Q3 2014. The put-call ratio across all filers is 0.59 and the average weighting 0.6%.

Quarter-by-quarter ownership
SCOTIA CAPITAL INC. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$4,320,030
+4.8%
44,766
+9.6%
0.03%
+10.7%
Q2 2023$4,121,469
+5.4%
40,842
-3.9%
0.03%
-3.4%
Q1 2023$3,911,954
+2.1%
42,513
+0.6%
0.03%0.0%
Q4 2022$3,833,357
+21.3%
42,247
+1.7%
0.03%
+11.5%
Q3 2022$3,159,000
-11.9%
41,557
-2.0%
0.03%
-3.7%
Q2 2022$3,584,000
-38.3%
42,403
-35.9%
0.03%
-27.0%
Q1 2022$5,806,000
-4.8%
66,165
-5.1%
0.04%
-7.5%
Q4 2021$6,101,000
-60.4%
69,756
-62.9%
0.04%
-64.3%
Q3 2021$15,396,000
-4.2%
188,266
+6.9%
0.11%
-5.1%
Q2 2021$16,066,000
-11.7%
176,083
-17.2%
0.12%
-20.3%
Q1 2021$18,188,000
+9.7%
212,774
+21.1%
0.15%
-2.6%
Q4 2020$16,585,000
+44.1%
175,633
+32.7%
0.15%
+21.6%
Q3 2020$11,509,000
+7.3%
132,348
+7.8%
0.12%
-16.7%
Q2 2020$10,723,000
+106.3%
122,720
+94.6%
0.15%
+108.3%
Q1 2020$5,199,000
-2.5%
63,054
+12.0%
0.07%
+22.0%
Q4 2019$5,333,000
+13.4%
56,318
+4.1%
0.06%
+7.3%
Q3 2019$4,703,000
+14.2%
54,123
+20.0%
0.06%
+10.0%
Q2 2019$4,120,000
-17.7%
45,116
-13.4%
0.05%
-21.9%
Q1 2019$5,006,000
+5.6%
52,089
-5.7%
0.06%
-8.6%
Q4 2018$4,741,000
+5.2%
55,257
+5.6%
0.07%
+22.8%
Q3 2018$4,507,000
+5.9%
52,307
-1.3%
0.06%
-3.4%
Q2 2018$4,257,000
+0.4%
52,973
+1.0%
0.06%
+1.7%
Q1 2018$4,238,000
-5.4%
52,433
-1.7%
0.06%
-3.3%
Q4 2017$4,480,000
-21.6%
53,348
-19.9%
0.06%
-25.9%
Q3 2017$5,717,000
+2.7%
66,603
-0.1%
0.08%
-13.8%
Q2 2017$5,567,000
+11.6%
66,694
-0.6%
0.09%
+10.6%
Q1 2017$4,989,000
+31.3%
67,124
+28.7%
0.08%
+39.3%
Q4 2016$3,800,000
-4.8%
52,136
+3.2%
0.06%
-16.4%
Q3 2016$3,990,000
+4.9%
50,541
+9.8%
0.07%
-5.2%
Q2 2016$3,802,000
+27.6%
46,012
+11.9%
0.08%
+18.5%
Q1 2016$2,980,000
+32.2%
41,118
+57.0%
0.06%
+27.5%
Q4 2015$2,254,000
-6.4%
26,1940.0%0.05%
-5.6%
Q3 2015$2,408,000
-7.2%
26,194
-0.6%
0.05%
+3.8%
Q2 2015$2,596,000
+2.5%
26,353
+2.6%
0.05%
-20.0%
Q1 2015$2,532,000
+2.8%
25,675
-3.5%
0.06%0.0%
Q4 2014$2,464,000
-50.0%
26,596
-49.2%
0.06%
-38.1%
Q3 2014$4,929,000
+3.9%
52,364
-0.1%
0.10%
+1.9%
Q2 2014$4,743,000
+6.5%
52,396
-0.0%
0.10%
+4.0%
Q1 2014$4,455,000
-3.7%
52,401
-8.9%
0.10%
-10.0%
Q4 2013$4,624,000
+5.9%
57,524
+1.1%
0.11%
-6.0%
Q3 2013$4,366,000
+95.6%
56,915
+80.6%
0.12%
+36.0%
Q2 2013$2,232,00031,5150.09%
Other shareholders
NOVARTIS A G shareholders Q3 2014
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders